已收盤 11-20 16:00:00 美东时间
-8.270
-9.22%
今日重点评级关注:康托·菲茨杰拉德:维持Lexeo Therapeutics"超配"评级,目标价从23美元升至37美元;摩根士丹利:维持Sana Biotechnology"超配"评级,目标价从12美元升至13美元
11-17 17:31
Cantor Fitzgerald analyst Derek Soderberg initiates coverage on Centrus Energy (NYSE:LEU) with a Overweight rating and announces Price Target of $130.
11-16 19:34
11月14日,Centrus Energy Corp. Class A(LEU)收跌0.13%,报103.78美元,成交额6840.73万美元,市值21.4亿美...
11-14 06:24
今日重点评级关注:瑞银:维持Liberty Media"中性"评级,目标价从110美元升至1116美元;杰富瑞:维持伊诺维奥制药"买入"评级,目标价从3美元升至8美元
11-09 14:00
Centrus Energy shares are trading higher after Roth Capital upgraded the stock from Neutral to Buy.
11-07 00:02
Roth Capital analyst Joe Reagor upgrades Centrus Energy (NYSE:LEU) from Neutral to Buy and maintains the price target from $115 to $115.
11-06 17:49
华盛资讯11月5日讯,Centrus Energy公布2026财年Q3业绩,公司Q3营收0.56亿美元,同比下降25.9%,归母净利润0.32亿美元,同比增长710.3%。
11-05 20:33
华盛资讯11月5日讯,Centrus Energy公布2026财年Q3业绩,公司Q3营收0.56亿美元,同比下降25.9%,归母净利润0.32亿美元,同比增长710.3%。
11-05 07:17
Centrus Energy (AMEX:LEU) reported quarterly losses of $(0.49) per share which missed the analyst consensus estimate of $(0.34) by 48.48 percent. This is a 357.89 percent decrease over earnings of $0.19 per share from the same period last year. The company reported quarterly sales of $55.500 million...
11-05 05:32
今日重点评级关注:BTIG:维持Cullinan Therapeutics"买入"评级,目标价从40美元升至41美元;Rosenblatt:维持SK海力士"买入"评级,目标价从320美元升至400美元
10-29 12:30